Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results Acq. announced Director departure CC transcript
|
ACHIEVE LIFE SCIENCES, INC. (ACHV)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/18/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
11/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
11/21/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/29/2021 |
SC 13G
| SVB FINANCIAL GROUP reports a 14.5% stake in Achieve Life Sciences, Inc. |
01/07/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
12/04/2020 |
SC 13G
| PACKER PAUL reports a 5.9% stake in Achieve Life Sciences, Inc. |
12/27/2019 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 10% stake in Achieve Life Sciences, Inc. |
12/26/2019 |
SC 13G
| CVI Investments, Inc. reports a 9.9% stake in Achieve Life Sciences, Inc. |
05/28/2019 |
SC 13G
| Adamas Health Care Fund reports a 5.4% stake in Achieve Life Sciences, Inc. |
02/14/2019 |
SC 13G
| Sio Capital Management, LLC reports a 8.9% stake in Achieve Life Sciences, Inc. |
02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/11/2018 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 7.6% stake in Achieve Life Sciences, Inc. |
07/03/2018 |
SC 13G
| HIRSCHMAN ORIN reports a 7.3% stake in Achieve Life Sciences, Inc. |
06/19/2018 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 6.5% stake in Achieve Life Sciences, Inc. |
08/11/2017 |
SC 13G
| MARTELL RON reports a 7.6% stake in ACHIEVE LIFE SCIENCES, INC. |
08/11/2017 |
SC 13G
| Schacter Robert reports a 16.7% stake in ACHIEVE LIFE SCIENCES, INC. |
04/10/2012 |
SC 13G
| ONCOGENEX PHARMACEUTICALS, INC. reports a 10.3% stake in ONCOGENEX PHARMACEUTICAL INC |
03/22/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/09/2012 |
SC 13G
| ONCOGENEX PHARMACEUTICALS, INC. reports a 5.8% stake in ONCOGENEX PHARMACEUTICALS INC |
08/31/2011 |
SC 13G
| ONCOGENEX PHARMACEUTICALS, INC. reports a 5% stake in OncoGenex Pharmaceuticals, Inc. |
03/14/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/14/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
06/10/2009 |
SC 13G
| Boxer Capital, LLC has filed a Schedule 13D for OncoGenex Pharmaceuticals, Inc. |
06/05/2009 |
SC 13G
| BLACK HORSE CAPITAL LP reports a 5.7% stake in OncoGenex Pharmaceuticals, Inc. |
|
|